Eli Lilly just struck a major deal with the world's largest retailer. GLP-1 drugs may have uses beyond obesity and diabetes ...

Thinking about what to do with Eli Lilly shares? You’re certainly not alone. The stock has been climbing the leaderboard for ...

Labcorp plans to offer Roche’s recently FDA-cleared blood test to assess early signs of Alzheimer’s disease and other causes ...

New blood tests could help doctors diagnose Alzheimer's disease faster and more accurately, researchers reported Sunday – but ...

Eli Lilly and Company (NYSE:LLY) is one of the stocks to invest in before they split next. On September 9, Eli Lilly and Company launched a new global campaign titled “Brain Health Matters” to ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. Featuring daily updates of ...

Julianne Moore had an important message for people watching the World Series this week, and I was one of them. Maybe you saw it, too?

Eli Lilly said it received marketing authorization from the European Commission for Kisunla, a treatment for early symptomatic Alzheimer's disease. Kisunla showed in a phase 3 trial that it can ...

Fresh off launching a national ad campaign to promote its Alzheimer’s treatment Kisunla, Eli Lilly is unveiling another effort focused on brain health — with some celebrity support. In 2015, Julianne ...

The EU medicines regulator on Friday rejected Eli Lilly's (LLY.N), opens new tab Alzheimer's drug, saying the treatment's ability to slow cognitive decline was not large enough to outweigh the risk of ...

Get the latest on Novo Nordisk's Alzheimer's trial, stock outlook, and market risks. See what investors need to know before ...